arsenic trisulfide has been researched along with Acute Promyelocytic Leukemia in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Chen, X; Jia, Y; Liu, Y; Zhang, M | 1 |
Cheng, X; He, P; Liu, F; Liu, Y; Shi, L; Tian, Y; Wang, Y; Zhang, M; Zhao, J; Zhou, N; Zhu, H | 1 |
Cheng, X; He, P; Liu, Y; Qi, J; Wang, C; Wang, Y; Zhang, M; Zhao, J; Zhu, H | 1 |
Bao, L; Huang, XJ; Jiang, B; Jiang, H; Jiang, Q; Lin, W; Liu, YR; Lu, J; Lu, XJ; Zhang, Y | 1 |
Gou, BD; Huang, J; Luo, LY; Wang, K; Zhang, TL | 1 |
5 other study(ies) available for arsenic trisulfide and Acute Promyelocytic Leukemia
Article | Year |
---|---|
Tetra-arsenic tetra-sulfide enhances NK-92MI mediated cellular immunotherapy in all-trans retinoic acid-resistant acute promyelocytic leukemia.
Topics: Animals; Arsenic; Arsenicals; Immunotherapy; Leukemia, Promyelocytic, Acute; Mice; Oxides; Sulfides; Tretinoin; Tumor Microenvironment | 2022 |
Arsenic sulfide promotes apoptosis in retinoid acid resistant human acute promyelocytic leukemic NB4-R1 cells through downregulation of SET protein.
Topics: Apoptosis; Arsenicals; Cell Line, Tumor; Cell Proliferation; Cell Shape; DNA-Binding Proteins; Down-Regulation; Drug Resistance, Neoplasm; Electrophoresis, Gel, Two-Dimensional; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Histone Chaperones; Humans; Leukemia, Promyelocytic, Acute; Oncogene Proteins, Fusion; Protein Phosphatase 2; Proteome; Proteomics; Retinoids; RNA, Messenger; RNA, Small Interfering; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sulfides; Transcription Factors | 2014 |
Prohibitin promotes apoptosis of promyelocytic leukemia induced by arsenic sulfide.
Topics: Antineoplastic Agents; Apoptosis; Arsenicals; Blotting, Western; Cell Line, Tumor; Electrophoresis, Gel, Two-Dimensional; Gene Knockdown Techniques; Humans; Leukemia, Promyelocytic, Acute; Prohibitins; Real-Time Polymerase Chain Reaction; Repressor Proteins; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sulfides; Tandem Mass Spectrometry; Transfection | 2015 |
[Effect of additional chromosome abnormalities on the outcome of newly diagnosed acute promyelocytic leukemia treated with red arsenic sulfide and all trans-retinoic acid plus anthracyclin based protocol].
Topics: Adolescent; Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Arsenicals; Chromosome Aberrations; Female; Follow-Up Studies; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Prognosis; Retrospective Studies; Sulfides; Treatment Outcome; Tretinoin; Young Adult | 2008 |
Induction of human promyelocytic leukemia HL-60 cell differentiation into monocytes by arsenic sulphide: involvement of serine/threonine protein phosphatases.
Topics: Arsenicals; Cell Differentiation; Cell Proliferation; Dose-Response Relationship, Drug; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Monocytes; Phosphoprotein Phosphatases; Serine; Structure-Activity Relationship; Sulfides; Threonine | 2006 |